RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Salt Lake City, UT · West Valley City, UT · +21 more sites
Clinical trials in West Valley City, UT
30 recruiting studies have a site in or near West Valley City, UT, Utah.
Top conditions here
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 30 of 30 studies
RecruitingPhase 1 / Phase 2NCT07038343
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Sponsor: Avenzo Therapeutics, Inc.
West Valley City, UT · +18 more sites
RecruitingPhase 1 / Phase 2NCT07070232
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Sponsor: BioNTech SE
West Valley City, UT · +18 more sites
RecruitingPhase 2NCT07745361
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Sponsor: Monte Rosa Therapeutics, Inc
West Valley City, UT · +13 more sites
RecruitingPhase 1 / Phase 2NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor: Genmab
West Valley City, UT · +36 more sites
RecruitingPhase 1NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Sponsor: Eli Lilly and Company
West Valley City, UT · +10 more sites
RecruitingPhase 1NCT06784193
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Sponsor: Olema Pharmaceuticals, Inc.
West Valley City, UT · +12 more sites
RecruitingPhase 1NCT06270706
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Sponsor: Pliant Therapeutics, Inc.
West Valley City, UT · +15 more sites
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Bountiful, UT · Ogden, UT · Salt Lake City, UT · +232 more sites
RecruitingPhase 1NCT07085091
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Sponsor: ALX Oncology Inc.
West Valley City, UT · +11 more sites
RecruitingPhase 1NCT07277413
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
West Valley City, UT · +22 more sites
RecruitingPhase 1NCT06004245
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Sponsor: Vividion Therapeutics, Inc.
West Valley City, UT · +15 more sites
RecruitingPhase 1NCT07746713
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
Sponsor: Janssen Research & Development, LLC
West Valley City, UT · +2 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
West Valley City, UT · +17 more sites
RecruitingPhase 1 / Phase 2NCT07332455
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Sponsor: GlaxoSmithKline
West Valley City, UT · +3 more sites
RecruitingPhase 1 / Phase 2NCT07491497
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Sponsor: TRIANA Biomedicines, Inc.
West Valley City, UT · +13 more sites
RecruitingPhase 1NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
Sponsor: MacroGenics
West Valley City, UT · +6 more sites
RecruitingPhase 1NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Sponsor: Pfizer
West Valley City, UT · +12 more sites
RecruitingPhase 1NCT06657144
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Sponsor: Coherus Oncology, Inc.
Salt Lake City, UT · West Valley City, UT · +18 more sites
RecruitingPhase 1 / Phase 2NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Sponsor: Eli Lilly and Company
West Valley City, UT · +27 more sites
RecruitingPhase 1NCT07300150
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Sponsor: PAQ Therapeutics, Inc.
West Valley City, UT · +4 more sites
RecruitingPhase 1NCT07046923
A Study of LY4175408 in Participants With Advanced Cancer
Sponsor: Eli Lilly and Company
West Valley City, UT · +14 more sites
RecruitingPhase 1NCT07503808
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Sponsor: IDEAYA Biosciences
West Valley City, UT · +14 more sites
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
West Valley City, UT · +10 more sites
RecruitingPhase 1NCT06723236
A Study of MGC028 in Participants With Advanced Solid Tumors
Sponsor: MacroGenics
West Valley City, UT · +6 more sites
RecruitingPhase 1 / Phase 2NCT06244771
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Sponsor: Frontier Medicines Corporation
West Valley City, UT · +14 more sites
RecruitingPhase 1NCT07190469
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer
Sponsor: ProteinQure Inc.
West Valley City, UT · +2 more sites
RecruitingPhase 1 / Phase 2NCT07030257
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Tasca Therapeutics
West Valley City, UT · +12 more sites
RecruitingPhase 1 / Phase 2NCT07145255
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Sponsor: MBrace Therapeutics
West Valley City, UT · +6 more sites
Not yet recruitingPhase 3NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
West Valley City, UT · +54 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.